RH Nanopharmaceuticals Company

RH/Nanopharma is a pharmaceutical research and development company dedicated to treating, preventing, slowing and reversing inflammatory diseases. Inflammation is at the heart of conditions such as osteoarthritis,type 2 diabetes, acute and chronic pain, traumatic brain injury, Alzheimer’s Disease, Dry Eye Disease (DED), inflammatory bowel disorders such as ulcerative colitis and Crohn’s Disease. RH NANO has reformulated a medication called salsalate which has been used for arthritis and diabetes for over 100 years. RH NANO is proud to be the first pharmaceutical company to successfully produce a nanoparticle of salsalate to be used in all the above mentioned inflammatory disorders. Salsalate in both standard and nanoparticle size is the safest anti-inflammatory/analgesic medicine known to physicians.

Headquarters: Monmouth Beach, New Jersey, United States
Technology: NeuroTech
Industry: Health Care, Pharmaceutical
Investor Type: For Profit